Product Images Noxafil
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 44 images provide visual information about the product associated with Noxafil NDC 0085-1328 by Merck Sharp & Dohme Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - noxafil 01
Chemical Structure - noxafil 02
Figure A - noxafil 02a
PRINCIPAL DISPLAY PANEL - 105 mL Bottle Carton - noxafil 03
NOXAFIL is an oral suspension medication that comes in a package of 105 mL. Each 5 mL contains 200mg of posaconazole. The medication comes with a measuring spoon for an accurate dosage. It is essential to note that NOXAFIL oral suspension and delayed-release tablets cannot be interchanged due to the difference in dosing. It is recommended to store the medication at 77°F and to shake the medication before consuming it.*
Principal Display Panel - 60 Tablet Bottle Label - noxafil 04
Noxafl is a prescription medication that comes in a delayed-release tablet form containing 100mg of posaconazole. The medication is not interchangeable with Noxafl Oral Suspension due to differences in dosing. The tablets should be stored at room temperature between 68-77°F and 59-86°F. The product has a National Drug Code (NDC) of 0085-4324-02 and a GTIN of 00300854324025. The package contains 60 tablets.*
Principal Display Panel - 16.7 mL Vial Carton - noxafil 05
Noxafil is an injectable medication containing 300mg posaconazole per 16.7 mL via, intended for intravenous use only. Inactive ingredients include 668 betadex suffobutyl ether sodium, 00033g edetate disodium, and hycochloric acid and sodium hydroxide to adjust the pH. The medication is manufactured for Merck Sharp & Dohme Corp, a subsidiary of Merck & Co, Inc. and manufactured by MSD International GmbH in Ireland. Noxafil is a clear, sterile solution that requires further dilution prior to infusion. The usual dosage information can be found in the accompanying directions, and any remaining solution should be stored in the refrigerator for up to 24 hours. The product is a sterile single-dose vial and requires a prescription.*
Figure - noxafil 06
Figure - noxafil 07
Figure - noxafil 08
Figure - noxafil 09
Figure - noxafil 10
Figure - noxafil 11
Figure - noxafil 12
Figure - noxafil 13
Figure - noxafil 14
Figure - noxafil 15
Figure - noxafil 16
Figure - noxafil 17
Figure - noxafil 18
Figure - noxafil 19
Figure - noxafil 20
Figure - noxafil 21
Figure - noxafil 22
Figure - noxafil 23
Figure - noxafil 24
Figure - noxafil 25
Figure - noxafil 26
Figure - noxafil 27
Figure - noxafil 28
Figure - noxafil 29
Figure - noxafil 30
Figure - noxafil 31
Figure - noxafil 32
Figure - noxafil 33
Figure - noxafil 34
Figure - noxafil 35
Figure - noxafil 36
Figure - noxafil 37
Figure - noxafil 38
Figure - noxafil 39
Figure - noxafil 40
Figure - noxafil 41
Figure - noxafil 42
Principal Display Panel - 300 mg Carton - noxafil 43
Noxafil PowderMix is an oral suspension containing 300mg of posaconazole. It is stored at a room temperature of 20 to 25°C and should be administered with the provided notched-tip syringes within an hour of mixing. The recommended dosage and usage instructions can be found in the prescribing information provided. The Multi-Dose Kit contains instructions for use, syringes, mixing liquid, bottle adapter, and 8 packets of Noxafil PowderMix. Additional notched-tip syringes are provided in Package B.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.